Instructions

Click on each of the categories to see the countries. Check the checkbox for what you want to see on the map. For more information about the map, click on any of the map icons or look at the text that appears on each of the maps, below them. For the “Solutions” section, hover over each part to get more information.

Data obtained from public sources. Data sent for review to country expert(s), although not all data has been reviewed by country experts.
For questions and feedback write an email to xxxx@gmail.com

Last Update: 19 May 2024

MOST COUNTRIES

MANY COUNTRIES

SOME COUNTRIES

FEW COUNTRIES

Area of application/type of solutionsLogin WebsitesAppsWebinarsMulti-disciplinary teleconferences (HCP-HPC)Teleconsultation (HCP-patient)Telemonitoring via devicesOther, please specify
EcosystemMost countries (23)
T,BE, BG, DE, CZ, EE,ES, FR, NL, PT, PL, CH, CY, LU, MT, SE, SK,FI,HR,HU,IT,LT,RO
Many countries (18)
AT, BE, BG, CH, CZ, DE, DK, FI, FR, HR, HU, LT, LU, MT, NL, PL, PT, SE
Some countries (10)
AT, BG, CH, FI, FR, LT, MT, PL, PT, SE
Some countries (10)
BG, CH, CZ, EE, ES, FR, LT, MT, PT, SE
Some countries (13)
AT, BE, CH, CZ, FI, FR, EE, LT, MT, NL, PT, RO, SE
Some countries (6)
BG, CZ, FR, PT, MT, SE
Some countries (9)
AT, BE, CZ, CH, DK, EE, FI FR, HU (general health information)
Prevention of CancerSome countries (7)
BG, EE, ES, LU, NL, PL, SE
Some countries (11)
AT, CY, DE, DK, EE, FR, IE, IT, PL, RO, SE
Some countries (8)
BG, CH, FR, IE, IT, LT, SE, SK
Few countries (3)
BG, LT, SK
Few countries (5)
BG, LT, LV, SE, SK
Few countries (3)
BG, LT, P
Some countries (7)
CZ, EE, ES, FI, FR, LT, RO (e.g., portal on screening programs, digital media advertising)
Treatment of CancerSome countries (7)
BG ,DE, FI, IT, LT, NL, RO
Some countries (15)
AT, BE, BG, CZ, DE, DK, EL, FI, FR, IE, IT, LT, LU, NL, PT
Some countries (9)
BG, CH, FI, FR, IT, LT, NL, RO, SE
Some countries (15)
AT, BE, BG, CH, CY, DE, DK, ES, FR, IE, NL, LU, LT, LV, SE
Some countries (14)
BE, BG, CZ, EE, EL, ES, FR, IT, LT, LV, NL, PT, SE, SK
Few countries (5)
BE, BG, CZ, FR, LT
Some countries (9)
CZ, EE, FI, FR, IE, LT, LU, NL, RO (e.g., National Cancer Control Programme info portal, symptom monitoring), events with virtual participation)
‘Living with cancer’Some countries (8)
BG ,ES, FI, IT, NL, LT, LV, SE
Some countries (8)
AT, BG, CH, CZ, DE, DK, EE, EL, FI, FR, IT, LT, NL, RO, SE
Some countries (7)
BG, CH, ES, FR, NL, LT, SE
Few countries (2)
BG, LT
Few countries (5)
BG, LT, LV, SE, SK
Few countries (4)
AT, CZ, LT, PT
Few countries (4)
AT, EE, NL, LT (e.g., pain symptom monitoring, survivorship passport)
Rehabilitation from CancerFew countries (5)
BG, FI, NL, LT, SE
Some countries (7)
BG, CZ, EE, FR, NL, PT, SE
Few countries (5)
BG, FR, LT, NL, SE
Few countries (3)
BG, LV, SE
Some countries (6)
BG, NL, LT, PT, SE, SK
Few countries (2)
CZ, LT
Few countries (1)
LT
Palliative Cancer CareFew countries (5)
BG, FI, NL, LT, SE
Few countries (5)
BG, CH, CZ, FR, LT
Few countries (3)
FR, LT, SE
Few countries (4)
BG, LT, LV, SE
Some countries (7)
BG, DK, ES, NL, LT, SE, SK
Few countries (3)
CZ, LT, SE
Few countries (2)
MT, LT (e.g., electronic referral form)

COUNTRIES INFORMATION

AUSTRIA

In Austria, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. There is also no certification or quality accreditation to assess the reliability of digital tools.

BELGIUM

In Belgium, there are public or commercial websites (such as mHealth Belgium) or other resources that are recommended to cancer patients or the general population. There are also certifications or quality accreditations to assess the reliability of digital tools (e.g. CE certification).

BULGARIA

In Bulgaria, there are public or commercial websites or other resources (such as еЗдраве) that are recommended to cancer patients or the general population. There are no certifications or quality accreditations to assess the reliability of digital tools.

SWITZERLAND

In Switzerland, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. However, there are certifications or quality accreditations to assess the reliability of digital tools stablished by eHealth Suisse.

CYPRUS

In Cyprus, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. There is also no certification or quality accreditation to assess the reliability of digital tools.

CZECH REPUBLIC

The Czech Republic does not provide information about websites or other resources recommended to cancer patients or the general population. Information on certifications or quality accreditations to assess the reliability of digital tools is also not available.

GERMANY

In Germany, there are public or commercial websites (such as Telehealth.de) or other resources that are recommended to cancer patients or the general population. There are also certifications or quality accreditations to assess the reliability of digital tools (e.g. Medizinproduktegesetz).

DENMARK

In Denmark, there are public or commercial websites or other resources (such as Min Læge) that are recommended to cancer patients or the general population. There are also certifications or quality accreditations under development to assess the reliability of digital tools.

ESTONIA

In Estonia, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. However, there are certifications or quality accreditations to assess the reliability of digital tools (e.g. Digilahenduste teejuht)

GREECE

Greece does not provide information about websites or other resources recommended to cancer patients or the general population. Information on certifications or quality accreditations to assess the reliability of digital tools is also not available.

SPAIN

In Spain, there are public or commercial websites (such as redescuelassalud.es) or other resources that are recommended to cancer patients or the general population. There is no information about certifications or quality accreditations to assess the reliability of digital tools.

FINLAND

In Finland, there are public or commercial websites or other resources (such as Noona) that are recommended to cancer patients or the general population. There are also certifications or quality accreditations to assess the reliability of digital tools (e.g. CEN ISO/TS 82304-2).

FRANCE

In France, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. However, there are certifications or quality accreditations to assess the reliability of digital tools (e.g. CE certification).

CROATIA

In Croatia, there are public or commercial websites (such as HZZO) or other resources that are recommended to cancer patients or the general population. There is no information about certifications or quality accreditations to assess the reliability of digital tools.

HUNGARY

Hungary does not provide information about websites or other resources recommended to cancer patients or the general population. Information on certifications or quality accreditations to assess the reliability of digital tools is also not available.

IRELAND

In Ireland, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. There is also no certification or quality accreditation to assess the reliability of digital tools.

ITALY

In Italy, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. Information on certifications or quality accreditations to assess the reliability of digital tools is not available.

LITHUANIA

In Lithuania, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. There is also no certification or quality accreditation to assess the reliability of digital tools.

LUXEMBOURG

In Luxembourg, there are public or commercial websites (such as eSanté) or other resources that are recommended to cancer patients or the general population. There is no information about certifications or quality accreditations to assess the reliability of digital tools.

LATVIA

In Latvia, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. Information on certifications or quality accreditations to assess the reliability of digital tools is not available.

MALTA

In Malta, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. Information on certifications or quality accreditations to assess the reliability of digital tools is not available.

NETHERLANDS

In the Netherlands, there are public or commercial websites (such as MedMij) or other resources that are recommended to cancer patients or the general population. There are also certifications or quality accreditations to assess the reliability of digital tools (e.g. ISO 82304-2).

NORWAY

Norway does not provide information about websites or other resources recommended to cancer patients or the general population. Information on certifications or quality accreditations to assess the reliability of digital tools is also not available.

POLAND

In Poland, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. There is also no certification or quality accreditation to assess the reliability of digital tools.

PORTUGAL

In Portugal, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. However, there are certifications or quality accreditations to assess the reliability of digital tools established by INFARMED.

ROMANIA

In Romania, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. There is also no certification or quality accreditation to assess the reliability of digital tools.

SWEDEN

In Sweden, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. However, there are certifications or quality accreditations to assess the reliability of digital tools (e.g. CE certification).

SLOVENIA

In Slovenia, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. Information on certifications or quality accreditations to assess the reliability of digital tools is not available.

SLOVAK REPUBLIC

In Slovakia, there are no public or commercial websites or other resources that are recommended to cancer patients or the general population. There is also no certification or quality accreditation to assess the reliability of digital tools.